Relative to the selective serotonin reuptake inhibitors (SSRIs), SB-649,915 has a faster onset of action and may also have greater clinical efficacy as well.
U odnosu na selectivne inhibitore preuzimanja serotonina (SSRI), SB-649,915 ima brži početak dejstva i verovatno ima veću kliničku efikasnost.